Yale Medical Group welcomes new physicians
Alexandra J. Lansky, MD, associate professor of medicine, is the new director of interventional cardiovascular research at Yale School of Medicine and codirector of the valve program at Yale-New Haven Hospital. She is dual board-certified in internal medicine and cardiovascular disease. Dr. Lansky’s clinical interests include interventional vascular therapy and women’s cardiovascular health. She has served as principal investigator for many angiographic and intravascular ultrasound core laboratory studies for interventional trials. Dr. Lansky earned her medical degree at the Medical College of Virginia, and completed her residency training in internal medicine, cardiology and interventional cardiology at the Washington Hospital Center in Washington, DC.
Roy S. Herbst, MD, PhD, a professor, is the new chief of medical oncology and associate director of translational research at Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven. Dr. Herbst is nationally recognized for his leadership and expertise in lung cancer treatment and research. Over the last several years, he has initiated novel, first-in-human clinical studies with several new treatments that are now approved for use in cancer patients. One of his pioneering studies was among the first to combine multiple molecular targeted agents for non-small cell lung cancer (NSCLC). Dr. Herbst completed his medical degree at Cornell University Medical College and his PhD in molecular cell biology at Rockefeller University. He completed his medical oncology fellowship at Dana Farber Cancer Institute and a medical hematology fellowship at Brigham and Women’s Hospital in Boston. He has a master’s degree from Harvard University’s clinical investigator training program.
Kevin P. Becker MD, PhD, is an assistant professor of neurology, board-certified in neurology. His clinical interests include all forms of primary brain tumors, consultative support for patients with systemic cancer that involve the central nervous system and difficult general neurology cases. He is working on the future establishment of a comprehensive care experience for patients with glioblastoma centering around data generated from the deep sequencing of the exome and genome of the tumor to guide personalized chemotherapy regimens. Dr. Becker’s current research focuses on bringing novel treatments to clinical trial for patients with primary brain tumors. He completed his medical degree at University of South Carolina College of Medicine, his residency in neurology at Yale-New Haven Hospital and a fellowship in neuro-oncology at Yale School of Medicine.
Lawrence J. Hirsch, MD, a professor of neurology, is the new chief of the Division of Epilepsy and EEG, and codirector of the Yale Comprehensive Epilepsy Center. Before joining Yale Medical Group, he was director of the epilepsy clinic at Columbia University, and he created and directed the Continuous EEG Monitoring Program at New York-Presbyterian Hospital/Columbia University Medical Center for the past decade. His research interests and publications cover such topics as brain monitoring in the critically ill, anti-epileptic drugs, sudden death in epilepsy, and treating refractory epilepsy with surgery and brain stimulation. Dr. Hirsch completed his medical degree at Yale School of Medicine and his neurology residency at Columbia University. He was chief resident of neurology at Columbia and the Neurological Institute of New York, where he also completed a two-year fellowship in Epilepsy/EEG.
Anthony F. Porto, MD, MPH, an assistant professor, is director of pediatric gastrointestinal programs at Greenwich Hospital, and is dual board-certified in pediatrics and pediatric gastroenterology. Dr. Porto has expertise in childhood obesity—particularly fatty liver diseases and high cholesterol—as well as inflammatory bowel disease and functional abdominal pain. Previously he directed a Fit Kids Obesity Program in New York. Dr. Porto completed his medical degree and master’s in public health from Tufts University School of Medicine. He finished his pediatric residency at Children’s Hospital at Montefiore Medical Center, and a fellowship in pediatric gastroenterology and hepatology at Children’s Hospital of New York-Presbyterian Medical Center.
Abeel A. Mangi, MD, an associate professor, is the new surgical director of the Center for Advanced Heart Failure, Mechanical Circulatory Support and Heart Transplantation. Board-certified as a thoracic surgeon, he specializes in complex and re-operative cardiac surgery, operations for end-stage heart failure, heart, heart-lung and lung transplantation and total artificial hearts, among other things. Dr. Mangi comes to Yale with considerable experience from Temple University in Philadelphia and the Cleveland Clinic. He completed his medical degree at Brown University, a general surgery residency at the Massachusetts General Hospital and Harvard Medical School and a cardiac surgery residency at Columbia University. In addition, Dr. Mangi completed fellowships in heart failure, mechanical circulatory support and heart transplantation at Columbia Presbyterian Medical Center; and in cell- and gene-based cardiovascular therapy at Brigham and Women's Hospital and Harvard Medical School. He is the recipient of a postdoctoral National Research Service Award fellowship, and has won awards from the American Heart Association and the American College of Cardiology for ground-breaking stem cell research.